Subsequently, a codon-optimized TCR was generated from these clones, and adoptive transfer of NPM1/HLA-A*02:01-specific TCR-transduced T cells specifically killed both AML cell lines and primary AML blasts and controlled tumor outgrowth and prolonged survival in a xenograft model (44). This evidence concerns the gene HLA-A and neoplasm.